It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Male gametes are generated through a specialised differentiation pathway involving a series of developmental transitions that are poorly characterised at the molecular level. Here, we use droplet-based single-cell RNA-Sequencing to profile spermatogenesis in adult animals and at multiple stages during juvenile development. By exploiting the first wave of spermatogenesis, we both precisely stage germ cell development and enrich for rare somatic cell-types and spermatogonia. To capture the full complexity of spermatogenesis including cells that have low transcriptional activity, we apply a statistical tool that identifies previously uncharacterised populations of leptotene and zygotene spermatocytes. Focusing on post-meiotic events, we characterise the temporal dynamics of X chromosome re-activation and profile the associated chromatin state using CUT&RUN. This identifies a set of genes strongly repressed by H3K9me3 in spermatocytes, which then undergo extensive chromatin remodelling post-meiosis, thus acquiring an active chromatin state and spermatid-specific expression.
The transcriptional regulation of murine spermatogenesis is not well understood. Here, the authors use single-cell and bulk RNA-Sequencing of juvenile and adult mice to characterise somatic and germ cell development, and chromatin profile the X chromosome to show that spermatid-specific genes are repressed by H3K9me3 during meiosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 European Bioinformatics Institute, (EMBL-EBI), Wellcome Genome Campus, European Molecular Biology Laboratory, Hinxton, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK (GRID:grid.470869.4) (ISNI:0000 0004 0634 2060)
2 University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK (GRID:grid.470869.4) (ISNI:0000 0004 0634 2060); Wellcome Sanger Institute, Welcome Genome Campus, Hinxton, Cambridge, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382)
3 European Bioinformatics Institute, (EMBL-EBI), Wellcome Genome Campus, European Molecular Biology Laboratory, Hinxton, Cambridge, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK (GRID:grid.470869.4) (ISNI:0000 0004 0634 2060); Wellcome Sanger Institute, Welcome Genome Campus, Hinxton, Cambridge, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382)
4 University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK (GRID:grid.470869.4) (ISNI:0000 0004 0634 2060); German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)